Bill Text: NH SB567 | 2024 | Regular Session | Amended

---

Bill Title: Directing the commissioner of the department of health and human services to compile a report on the availability of mifepristone and misoprostol.

Spectrum: Partisan Bill (Democrat 14-0)

Status: (Engrossed - Dead) 2024-05-23 - Lay SB567 on Table (Rep. Weber): Motion Adopted DV 302-54 05/23/2024 House Journal 14 P. 106 [SB567 Detail]

Download: New_Hampshire-2024-SB567-Amended.html

---

SB 567-FN - AS AMENDED BY THE SENATE

 

02/15/2024   0714s

2024 SESSION

24-3103

05/08

 

SENATE BILL 567-FN

 

AN ACT directing the commissioner of the department of health and human services to compile a report on the availability of mifepristone and misoprostol.

 

SPONSORS: Sen. Whitley, Dist 15; Sen. D'Allesandro, Dist 20; Sen. Rosenwald, Dist 13; Sen. Soucy, Dist 18; Sen. Perkins Kwoka, Dist 21; Sen. Altschiller, Dist 24; Sen. Watters, Dist 4; Sen. Fenton, Dist 10; Sen. Chandley, Dist 11; Sen. Prentiss, Dist 5; Rep. Brennan, Merr. 9; Rep. Hakken-Phillips, Graf. 12; Rep. M. Murray, Hills. 37; Rep. Toll, Ches. 15

 

COMMITTEE: Judiciary

 

-----------------------------------------------------------------

 

AMENDED ANALYSIS

 

This bill directs the commissioner of the department of health and human services to compile a report on the availability of mifepristone and misoprostol.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

02/15/2024   0714s 24-3103

05/08

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Twenty Four

 

AN ACT directing the commissioner of the department of health and human services to compile a report on the availability of mifepristone and misoprostol.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

1   Department of Health and Human Services; Report; Availability of Mifepristone and Misoprostol.  

I.  The commissioner of the department health and human services or designee shall submit a report to the senate president, the speaker of the house of representatives, the house clerk, and the senate clerk by November 1, 2024:

(a)  Identifying potential actions to protect and expand access to mifepristone and misoprostol;

(b)  Identifying ways to increase outreach and education about access to mifepristone and misoprostol; and

(c)  Identifying barriers to protecting or expanding access to mifepristone and misoprostol.

  II.  Nothing in this section shall diminish any existing authority of the department, or require the department to conduct any activity in violation of state or federal law.

III.  No general funds shall be appropriated for the purposes of completing this report.  The department shall seek and apply for any appropriate grants and federal funds available to complete this report. 

  2  Effective Date.  This act shall take effect upon its passage.

 

LBA

24-3103

Revised 12/26/23

 

SB 567-FN- FISCAL NOTE

AS INTRODUCED

 

AN ACT relative to protecting and expanding access to abortion medications.

 

FISCAL IMPACT:      [ X ] State              [    ] County               [    ] Local              [    ] None

Estimated State Impact - Increase / (Decrease)
		FY 2024	FY 2025		FY 2026	FY 2027
Revenue		$0	$0		$0	$0
Revenue Fund(s)		None
Expenditures		$0	$109,000		$106,000	$109,000
Funding Source(s)		General Fund
Appropriations		$0	$0		$0	$0
Funding Source(s)		None
• Does this bill provide sufficient funding to cover estimated expenditures? [X] No • Does this bill authorize new positions to implement this bill? [X] No

 

METHODOLOGY:

This bill requires the Department of Health and Human Services to protect and expand access to medications for reproductive health, including medication abortion.  The Department anticipates that it will need to hire a new staff position (Program Specialist IV, labor grade 25) to oversee the work required by the bill, including researching, collecting information, and publishing the required report. The Department is unable to estimate the additional costs associated with protecting and increasing access to medication abortion, but it assumes that the new staff position will also be responsible for those activities.  The Department is also unable to determine whether there will be costs in FY26 and FY27, as the bill is not specific with respect to the Department’s responsibilities to “protect and expand access." Assuming the position will continue through at least FY27, salary, benefits, and related expenses will cost $109,000 in FY25, $106,000 in FY26, and $109,000 in FY27.

 

The Department notes that current federal and general funds appropriated to for family planning and reproductive health are prohibited from being used for abortion-related activities. Current Department resources may be used only to identify ways to increase outreach and education about contraception and access to preventative health care services.

 

AGENCIES CONTACTED:

Department of Health and Human Services